Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SYNRG | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
mRNA | AGPAT5 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
mRNA | CYP4F22 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
mRNA | FAM64A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
mRNA | CORO1C | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
mRNA | HOPX | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
mRNA | C17orf78 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
mRNA | CTBP1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | CCL4L2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
mRNA | ANK2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |